Research shows that several experimental treatments can reduce suicidal thoughts within days to weeks, faster than traditional antidepressants. According to Gram Research analysis of 34 recent studies, NMDA-related drugs, buprenorphine, and brain stimulation techniques like repetitive magnetic pulses showed the most promise. Some treatments reduced suicidal thoughts independently of mood improvement, suggesting they target suicidal thinking directly. However, most remain experimental and require further testing before widespread approval.
Researchers reviewed 34 studies from the past decade on new medicines and brain treatments that might help people having suicidal thoughts or who have attempted suicide. According to Gram Research analysis, some treatments like certain NMDA drugs, buprenorphine, and brain stimulation techniques showed promise in reducing suicidal thoughts within days or weeks. While current treatments often take weeks to work or have side effects, these emerging options offer hope for faster relief. However, most are still being tested and aren’t officially approved for treating suicidal thoughts yet. The review highlights which treatments look most promising and what researchers need to study next.
Key Statistics
A 2026 narrative review of 34 studies found that experimental treatments reduced suicidal thoughts within days to weeks, compared to the typical 4-6 week timeline for standard antidepressants to show effects.
Among 22 pharmacological studies reviewed in 2026, NMDA-related drugs and buprenorphine showed the most encouraging results for reducing suicidal ideation, with some improvements occurring independently of depression score changes.
A 2026 analysis of 12 neuromodulation studies identified repetitive transcranial magnetic stimulation, theta-burst stimulation, and magnetic seizure therapy as effective for reducing suicidal thoughts, with vagus nerve stimulation showing longer-term benefits in real-world use.
In observational studies reviewed in 2026, folic acid supplementation, benztropine, and testosterone therapy in transgender adults were associated with lower suicidality, while non-medical cannabis use was linked to worse suicidal thought trajectories.
The Quick Take
- What they studied: New medicines and brain stimulation treatments that might help people experiencing suicidal thoughts or who have tried to hurt themselves, focusing on treatments not yet officially approved for this purpose.
- Who participated: The review analyzed 34 studies involving adults with suicidal thoughts or suicide attempts. Studies included both controlled experiments (22 drug studies, 12 brain stimulation studies) and real-world observations from hospitals and clinics.
- Key finding: Several experimental treatments reduced suicidal thoughts within days to weeks, faster than many current medications. Some worked independently of mood improvement, suggesting they target suicidal thinking directly rather than just treating depression.
- What it means for you: If you or someone you know struggles with suicidal thoughts, these emerging treatments offer hope for faster relief than traditional options. However, most are still in testing phases. Talk to a mental health professional about whether any might be appropriate—never stop current treatments without medical guidance.
The Research Details
Researchers conducted a narrative review, which means they searched medical databases for all studies published in the last decade about new treatments for suicidal thoughts and attempts. They looked for studies involving adults and included both controlled experiments (where some people get the treatment and others don’t) and real-world observations from hospitals and clinics.
They found 34 studies total: 22 focused on new medicines and 12 on brain stimulation techniques. Some studies measured how well treatments worked in controlled settings (efficacy), while others tracked how well they worked in real hospitals and clinics (effectiveness). This mix of study types gives a fuller picture of what might actually help people.
The researchers looked specifically at whether treatments reduced suicidal thoughts and whether this improvement happened separately from improvements in depression. This matters because it shows whether a treatment targets suicidal thinking directly or just helps by treating depression.
This research approach is important because suicide is a major health problem worldwide, and current treatments have limitations. Many medications take weeks to work, and some people can’t tolerate the side effects. By reviewing all recent studies together, researchers can identify which new approaches show the most promise and guide future testing. Understanding which treatments work fastest and most directly on suicidal thoughts could save lives.
This is a narrative review, which means it provides a comprehensive overview but relies on researchers’ judgment about which studies to include. The strength is that it covers diverse treatment approaches across 34 studies. The limitation is that narrative reviews don’t use strict statistical methods like meta-analyses do. The findings represent promising early evidence, not definitive proof. Most treatments discussed are still experimental and need larger, longer studies before becoming standard care.
What the Results Show
Several medication approaches showed encouraging results. NMDA-related drugs (NRX-101 and high-dose d-cycloserine) and buprenorphine at different doses showed the most promise for reducing suicidal thoughts. Ayahuasca, a plant-based substance, showed benefits in people with severe depression that hadn’t responded to other treatments. Pimavanserin, when added to other medications, also helped reduce suicidal thoughts.
Importantly, in many controlled trials, suicidal thoughts improved within days to weeks—much faster than traditional antidepressants typically work. Some studies showed that this improvement happened even when depression scores didn’t change as much, suggesting these treatments might work directly on suicidal thinking rather than just by treating depression.
Brain stimulation techniques also showed promise. Repetitive transcranial magnetic stimulation (a non-invasive technique using magnetic pulses), theta-burst stimulation (a faster version), and magnetic seizure therapy all reduced suicidal thoughts. Vagus nerve stimulation (a surgical implant that sends electrical signals to the brain) showed longer-term benefits in real-world use.
Observational studies from large hospital datasets found associations between lower suicidal thoughts and several factors: folic acid supplementation, benztropine (a medication for movement disorders), testosterone therapy in transgender adults, and certain blood thinners. Interestingly, non-medical cannabis use was associated with worse suicidal thought patterns. Smaller effects were seen with vortioxetine (an antidepressant) when added to other treatments and with zolpidem (a sleep medication) targeting insomnia.
This review updates previous knowledge by synthesizing a decade of newer research on treatments specifically targeting suicidal thoughts. Traditional approaches focused mainly on treating depression, assuming that reducing depression would reduce suicidal thoughts. These newer treatments suggest a different approach: some may directly reduce suicidal thinking independent of mood changes. This represents a shift toward suicide-specific treatments rather than depression-focused ones.
The review has several important limitations. Most studies were small and short-term, so we don’t know if benefits last. Many treatments haven’t been compared head-to-head, making it hard to know which works best. Some findings came from observational studies, which can’t prove cause-and-effect like controlled trials can. Different studies measured suicidal thoughts differently, making comparisons difficult. Most treatments aren’t officially approved for suicidal thoughts yet, so they’re not widely available. The review couldn’t determine which patients would benefit most from which treatments.
The Bottom Line
If you experience suicidal thoughts, seek immediate help from a mental health professional or crisis line. Current standard treatments (therapy and approved medications) remain important first steps. These emerging treatments show promise but are mostly still experimental. Discuss with your doctor whether participating in research studies or accessing these treatments through specialized clinics might be appropriate for your situation. Never stop current treatments without medical guidance. Confidence level: Moderate—these are promising early findings requiring further research.
Anyone experiencing suicidal thoughts or attempts should know these options exist and discuss them with mental health professionals. Family members and caregivers should understand that newer, faster-acting treatments are being developed. Mental health providers should stay informed about emerging options for treatment-resistant cases. People with severe depression that hasn’t responded to standard treatments may particularly benefit from learning about these approaches.
In controlled trials, some treatments reduced suicidal thoughts within days to weeks, much faster than traditional antidepressants (which typically take 4-6 weeks). However, most of these treatments are still experimental. If approved and made available, realistic timelines for widespread access are likely 2-5 years for most options. Long-term benefits and durability remain unclear and need more research.
Frequently Asked Questions
What new treatments are being tested for suicidal thoughts?
Researchers are testing NMDA-related drugs, buprenorphine, ayahuasca, and brain stimulation techniques like magnetic pulses. A 2026 review of 34 studies found these approaches reduced suicidal thoughts within days to weeks, faster than traditional medications. Most remain experimental and not yet officially approved.
How fast do these new treatments work compared to regular antidepressants?
Experimental treatments showed improvements within days to weeks, while standard antidepressants typically take 4-6 weeks. Some treatments reduced suicidal thoughts even when depression didn’t improve as much, suggesting they work directly on suicidal thinking rather than just treating mood.
Are these treatments available to use right now?
Most are still in research phases and not officially approved for treating suicidal thoughts. Some may be available through specialized clinics or research studies. Talk to a mental health professional about whether you might qualify for experimental treatment programs in your area.
What should I do if I’m having suicidal thoughts?
Contact a crisis line immediately (988 in the US), go to an emergency room, or call emergency services. Work with a mental health professional on proven treatments like therapy and approved medications. Discuss emerging options with your doctor as part of your overall treatment plan.
Do these treatments work better than current medications for everyone?
Not necessarily. The review found promising results, but most studies were small and short-term. Different people respond differently to treatments. Work with your mental health provider to find what works best for your specific situation, combining proven approaches with emerging options when appropriate.
Want to Apply This Research?
- Track suicidal thought intensity daily on a 0-10 scale, noting the time of day and any triggers. Record whether you’re sleeping well, as insomnia appears linked to suicidal thoughts. If trying new treatments, note the date started and any changes in thought patterns within the first week.
- Use the app to set reminders for crisis resources and mental health appointments. Create a safety plan within the app listing warning signs of increased suicidal thoughts and immediate actions to take. Log conversations with your doctor about emerging treatments so you remember details to discuss at next visits.
- Establish a baseline of your current suicidal thought patterns before any treatment change. Check in weekly with your tracking data to spot trends. Share monthly summaries with your mental health provider to guide treatment decisions. Use the app to monitor whether improvements happen quickly (days-weeks) or gradually, helping identify which treatments might work best for you.
This article reviews emerging research on experimental treatments for suicidal thoughts and attempts. These treatments are mostly not yet officially approved and should only be pursued under professional medical supervision. If you or someone you know is experiencing suicidal thoughts, seek immediate help by contacting a crisis line (988 in the US), visiting an emergency room, or calling emergency services. This information is educational and not a substitute for professional mental health care. Always consult with a qualified mental health professional before starting, stopping, or changing any treatment. The findings presented represent early-stage research and should not be interpreted as definitive medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.